While the Biden administration is working toward conducting a review into the federal scheduling for marijuana, a coalition of bipartisan congressional lawmakers is requesting Biden to stand behind marijuana legalization.
“We might not frequently agree on particular measures, but we understand that continued federal marijuana criminalization and prohibition is not the will of the American citizenry. Therefore, the administration should acknowledge the scheduling review directive and also be cognizant of the advantages of full descheduling,” says the letter. Advocates plan to deliver the letter to Biden’s top cabinet officers over the coming days. This letter was obtained by various media desks.
“Marijuana should not be classified as a dangerous substance with high abuse potential and no medicinal purpose. Hence it shouldn’t be placed in the Controlled Substance Act,” the letter also says.
Notable signatures on the letter include Senator Elizabeth Warren; Congress cannabis caucus representatives Earl Blumenauer, Dave Joyce and Brian Mast as well as Barbara Lee. Additional signatures are sought before the letter reaches the president and his cabinet.
“Descheduling marijuana can propel federal authority to regulate cannabis; allowing states which wish to continue prohibiting cannabis sales and production to do so. The federal government needs to nullify the criminalization of otherwise legal marijuana and allow research to advance unrestricted. In doing so, this could open up job opportunities, cease unjust incarceration, promote the safety of the public and uphold state regulations of production, taxation and sale of cannabis.
“We do not trivialize the importance of legislative ACTION and federal guidance, but the federal government should magnify the importance of de-scheduling marijuana in a manner that protects the will of states, markets and regulations within their (state) authority to establish,” the letter continued.
The congressional lawmakers were circulating this letter as leaders worked to enact more legislation on marijuana banking and expungement within the little time left; those efforts fell flat. Advocates are looking to see wider legalization enacted sooner, but it seems there isn’t enough senate support to reach the 60-vote threshold for passage. Descheduling ends punitive marijuana prohibition by the federal government and helps law enforcers to prioritize public safety.
US Health and Human Services secretary Becerra has said the department would expedite a scientific review, and discussions are ongoing with FDA senior officials on the same. President Joseph Biden has signed a marijuana bill into law making this a primary standalone cannabis legislation in the history of the United States.
Industry participants such as India Globalization Capital Inc. (NYSE American: IGC) are probably going to watch events as they develop on Capitol Hill to see which policy direction is likely to emerge from the marijuana scheduling review process.
NOTE TO INVESTORS: The latest news and updates relating to India Globalization Capital Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
